Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03070027 5-HEPE cPLA2i 1.0 BCD110605C28 0.149 pmol/ml medium
LMFA03070027 5-HEPE cPLA2i 1.0 BCD110605C30 0.169 pmol/ml medium
LMFA03070027 5-HEPE cPLA2i 1.0 BCD110605C29 0.183 pmol/ml medium
LMFA03070027 5-HEPE cPLA2i 20.0 BCD110605C64 0.377 pmol/ml medium
LMFA03070027 5-HEPE cPLA2i 20.0 BCD110605C66 0.32 pmol/ml medium
LMFA03070027 5-HEPE cPLA2i 20.0 BCD110605C65 0.324 pmol/ml medium
LMFA03070027 5-HEPE PLDi 1.0 BCD110605C16 0.163 pmol/ml medium
LMFA03070027 5-HEPE PLDi 1.0 BCD110605C17 0.164 pmol/ml medium
LMFA03070027 5-HEPE PLDi 1.0 BCD110605C18 0.154 pmol/ml medium
LMFA03070027 5-HEPE PLDi 20.0 BCD110605C54 0.437 pmol/ml medium
LMFA03070027 5-HEPE PLDi 20.0 BCD110605C52 0.424 pmol/ml medium
LMFA03070027 5-HEPE PLDi 20.0 BCD110605C53 0.463 pmol/ml medium
LMFA03070027 5-HEPE KDO+cPLA2i 1.0 BCD110605C32 0.158 pmol/ml medium
LMFA03070027 5-HEPE KDO+cPLA2i 1.0 BCD110605C31 0.155 pmol/ml medium
LMFA03070027 5-HEPE KDO+cPLA2i 1.0 BCD110605C33 0.135 pmol/ml medium
LMFA03070027 5-HEPE KDO+cPLA2i 20.0 BCD110605C68 0.368 pmol/ml medium
LMFA03070027 5-HEPE KDO+cPLA2i 20.0 BCD110605C69 0.317 pmol/ml medium
LMFA03070027 5-HEPE KDO+cPLA2i 20.0 BCD110605C67 0.32 pmol/ml medium
LMFA03070027 5-HEPE KDO+PLDi 1.0 BCD110605C19 0.119 pmol/ml medium
LMFA03070027 5-HEPE KDO+PLDi 1.0 BCD110605C20 0.124 pmol/ml medium
LMFA03070027 5-HEPE KDO+PLDi 1.0 BCD110605C21 0.141 pmol/ml medium
LMFA03070027 5-HEPE KDO+PLDi 20.0 BCD110605C56 0.446 pmol/ml medium
LMFA03070027 5-HEPE KDO+PLDi 20.0 BCD110605C57 0.417 pmol/ml medium
LMFA03070027 5-HEPE KDO+PLDi 20.0 BCD110605C55 0.459 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+cPLA2i 1.0 BCD110605C37 0.131 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+cPLA2i 1.0 BCD110605C38 0.128 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+cPLA2i 1.0 BCD110605C39 0.11 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+cPLA2i 20.0 BCD110605C74 0.21 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+cPLA2i 20.0 BCD110605C75 0.178 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+cPLA2i 20.0 BCD110605C73 0.205 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+PLDi 1.0 BCD110605C25 0.114 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+PLDi 1.0 BCD110605C27 0.111 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+PLDi 1.0 BCD110605C26 0.116 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+PLDi 20.0 BCD110605C61 0.189 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+PLDi 20.0 BCD110605C62 0.201 pmol/ml medium
LMFA03070027 5-HEPE KDO+ATP+PLDi 20.0 BCD110605C63 0.206 pmol/ml medium
LMFA03070027 5-HEPE KDO + ATP 1.0 BCD110605C15 0.12 pmol/ml medium
LMFA03070027 5-HEPE KDO + ATP 1.0 BCD110605C14 0.125 pmol/ml medium
LMFA03070027 5-HEPE KDO + ATP 1.0 BCD110605C13 0.155 pmol/ml medium
LMFA03070027 5-HEPE KDO + ATP 20.0 BCD110605C49 0.245 pmol/ml medium
LMFA03070027 5-HEPE KDO + ATP 20.0 BCD110605C50 0.253 pmol/ml medium
LMFA03070027 5-HEPE KDO + ATP 20.0 BCD110605C51 0.206 pmol/ml medium
LMFA03070027 5-HEPE KDO 1.0 BCD110605C08 0.133 pmol/ml medium
LMFA03070027 5-HEPE KDO 1.0 BCD110605C07 0.102 pmol/ml medium
LMFA03070027 5-HEPE KDO 1.0 BCD110605C09 0.108 pmol/ml medium
LMFA03070027 5-HEPE KDO 20.0 BCD110605C45 0.401 pmol/ml medium
LMFA03070027 5-HEPE KDO 20.0 BCD110605C44 0.465 pmol/ml medium
LMFA03070027 5-HEPE KDO 20.0 BCD110605C43 0.417 pmol/ml medium
LMFA03070027 5-HEPE C 0.0 BCD110605C03 0.075 pmol/ml medium
LMFA03070027 5-HEPE C 0.0 BCD110605C01 0.162 pmol/ml medium